SGLT2 inhibitors and kidneys: mechanisms and main effects in diabetes mellitus patients

SGLT2 inhibitors and kidneys: mechanisms and main effects in diabetes mellitus patients

Type 2 diabetes mellitus (T2DM) is the cause of the development of diabetic nephropathy — a complication that determines the high degree of disability and mortality of such patients. Until recently, approaches to normalizing glucose levels did not have a significant possibility of influencing the ou...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vladimir V Salukhov, Yurii Sh. Khalimov, Sergey B. Shustov, Sergey I. Popov
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2021
Materias:
type 2 diabetes mellitus
diabetic nephropathy
end-stage renal disease
albuminuria
glomerular filtration rate
nephroprotection
type 2 sodium glucose cotransporter inhibitors
Nutritional diseases. Deficiency diseases
RC620-627
Acceso en línea:https://doaj.org/article/5c7f859deb01455f8bc09e299148dcde
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares